BTG2 antagonizes Pin1 in response to mitogens and telomere disruption during replicative senescence

• Published in: Aging cell 2010-10, Vol.9 (5), p.747-760
• Main Authors: Wheaton, Keith, Muir, Jennifer, Ma, Weili, Benchimol, Samuel
• Format: Article
• Language: English
• Subjects: BTG2; Cell Proliferation; Cells, Cultured; Cellular Senescence; Fibroblasts - cytology; Fibroblasts - metabolism; Humans; Immediate-Early Proteins - genetics; Immediate-Early Proteins - metabolism; Mitogens - metabolism; NIMA-Interacting Peptidylprolyl Isomerase; p53; Peptidylprolyl Isomerase - metabolism; Pin1; replicative; senescence; Signal Transduction; Telomere - metabolism; telomeres; Tumor Suppressor Protein p53 - metabolism; Tumor Suppressor Proteins - genetics; Tumor Suppressor Proteins - metabolism
• ISSN: 1474-9718; 1474-9726
• DOI: 10.1111/j.1474-9726.2010.00601.x

Summary Cellular senescence limits the replicative capacity of normal cells and acts as an intrinsic barrier that protects against the development of cancer. Telomere shortening–induced replicative senescence is dependent on the ATM‐p53‐p21 pathway but additional genes likely contribute to senescence. Here, we show that the p53‐responsive gene BTG2 plays an essential role in replicative senescence. Similar to p53 and p21 depletion, BTG2 depletion in human fibroblasts leads to an extension of cellular lifespan, and ectopic BTG2 induces senescence independently of p53. The anti‐proliferative function of BTG2 during senescence involves its stabilization in response to telomere dysfunction followed by serum‐dependent binding and relocalization of the cell cycle regulator prolyl isomerase Pin1. Pin1 inhibition leads to senescence in late‐passage cells, and ectopic Pin1 expression rescues cells from BTG2‐induced senescence. The neutralization of Pin1 by BTG2 provides a critical mechanism to maintain senescent arrest in the presence of mitogenic signals in normal primary fibroblasts.